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PVNS is a rare disorder characterised by benign prolifera-
tion of synovial tissue. The treatment is surgical but
relapse rate is high (8% to 46%). We report a 13 years old
girl with PVNS of the left knee diagnosed in February
2003. Three months after diagnosis she underwent surgi-
cal synovectomy. Two years later important swelling of
left knee with pain and limitation of movement devel-
oped and MRI confirmed the relapse of PVNS. She was
treated with 3 intraarticular injections of etanercept two
months apart with mild reduction of fluid but not of syn-
ovial hypertrophy. In November 2006 radiosynoviorthe-
sis with one intraarticular injection of 186Re was
performed. No side effects were reported and patient pre-
sented an important reduction of pain and improvement
of range of motion. Six months after the procedure MRI
showed marked decrease of fluid accumulation, and a
mild reduction of synovial hypertrophy. One further
intraarticular injection of 186Re has been performed 18
months after the first in order to obtain a more complete
effect on synovial thickening.
In our case radiosynoviorthesis has been showed as a safe
and effective treatment in relapsing PVNS, which can be
considered both as alternative to surgical synovectomy
and complementary to it in order to obtain a more persist-
ent remission of the disease. The collaboration between
paediatric rheumatologist, nuclear physician and ortho-
paedic surgeon is fundamental in establishing the timing
of the procedure as well as type and dose of radioisotope
to be used according to the age of the patient and the
PVNS extension.
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